Want to hear more about the Reproductive Health Hotline (ReproHH) and other useful resources for healthcare providers?
Principal Investigator Dr. Jen Karlin recently sat down for the Afaxys Candid Conversations in Public Health podcast, where she discusses the launch of ReproHH as a free, nationwide service that provides real-time confidential support for clinicians managing questions about contraceptive care and reproductive health.
Dr. Karlin and the hosts also explore how clinicians can stay up-to-date in sexual and reproductive health (SRH) while balancing evolving evidence, patient needs, and time constraints. In addition to ReproHH, the discussion covers helpful tools and practical continuing medical education strategies.
Watch the episode, "Clinician Resources for Lifelong Learning: On the Front Lines of Sexual & Reproductive Health" below:
To utilize the hotline, call 1-844-ReproHH (844-737-7644) after reading our Terms…
It's been an exciting few months following the launch of the Reproductive Health Hotline (ReproHH) this summer. As a resource for all U.S.-based clinicians and community health workers, we've enjoyed guiding callers through their questions about sexual and reproductive health (SRH) using evidence-based best practices.
As a new resource, it's important to get the word out about our hotline, and ensure providers are aware that our free and confidential service is available to them. That's why we are proud to share that ReproHH has been featured in MedPage Today®, a popular online news service for healthcare professionals!
The article "Physicians Can Call New Hotline With Reproductive Health Questions" covers the launch of ReproHH, which was one of our inspirations, and our process for taking calls in and out of California. As a reminder, all callers must read and acknowledge our Terms of Service before receiving clinical education from our staff.
Read below for a snippet from the article, and read the full article on MedPage Today…
Last week, we crossed an exciting milestone here at the Reproductive Health Hotline: Answering our 100th call! Since our launch this summer, call volume has been growing steadily, and we are pleased to have surpassed the triple-digit mark.
The topic of our 100th call was on Mycoplasma genitalium, sometimes known as “Mgen."
What is Mgen?
Mgen is a lesser-known sexually transmitted infection (STI) that is often asymptomatic, but can also be a potential source for cervicitis, urethritis, or potentially pelvic inflammatory disease (PID).
How Should I Manage Mgen?
Mgen should always be tested for when a patient is experiencing recurrent or refractory symptoms, either through urine or a vaginal swab.
Because Mgen often demonstrates macrolide resistance, treatment is a two-step process: The sequential use of doxycycline first to decrease bacterial load, followed by moxifloxacin for a >90% success rate.
Resources
A few good resources to learn more about Mgen include the CDC Treatment Guidelines or the…